compound introduction
AT-56 是一种有效，选择性和具有口服活性的脂钙蛋白型前列腺素 D 合酶 (L-PGDS) 的抑制剂，IC50 值为 95 μM，Ki 值为 75 μM。AT-56 可选择性抑制 L-PGDS 催化的 PGD2 介导的嗜睡或疼痛反应。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
AT-56
Dangerous GoodsCAS number：162640-98-4 molecular formula：C25H27N5
overview
Specs
| Chinese alias | - | ||
| English alias | BCP08667 | J-009959 | EX-A272 | FT-0700233 | MFCD18086874 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine | AS-16433 | AKOS024457667 | 1-[4-(2H-tetrazol-5-yl)butyl]-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13 | ||
| CAS number | 162640-98-4 | molecular formula | C25H27N5 |
| molecular weight | 397.52 g/mol | Exact mass | - |
| PSA | 57.700 Ų | logp | 4.900 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
WGK Germany：
3
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
